Company intelligence / Profile preview
Apontis Pharma AG
Monheim am Rhein, Germanyapontis-pharma.de ↗
- Ownership
- Private
- Employees
- ~177
- Development stage
- Commercial
01
Overview
The company has successfully launched eleven Single Pills on the market since 2013, with medicines used to treat hundreds of thousands of patients.
- Therapeutic areas
- PulmonologyCardiovascularEndocrinologyInfectious Diseases
- Modalities
- Single Pills (combination products)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Various pharmaceutical companies (specific names not provided)
Beyond the preview
Go deeper on Apontis Pharma AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apontis Pharma AG.